NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Anavex Life Sciences Corp. (LSE: 0HFR)

 
0HFR Technical Analysis
5
As on 21st Nov 2024 0HFR STOCK Price closed @ 9.36 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.56 & Strong Buy for SHORT-TERM with Stoploss of 8.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

0HFRSTOCK Price

Open 8.49 Change Price %
High 9.37 1 Day 1.57 20.15
Low 8.40 1 Week 0.30 3.31
Close 9.36 1 Month 3.95 73.01
Volume 6461 1 Year 0.63 7.22
52 Week High 9.86 | 52 Week Low 3.45
 
LSE UK Most Active Stocks
NTOG 0.02 -50.00%
TRP 0.03 0.00%
VELA 0.01 %
MSMN 0.04 0.00%
UKOG 0.02 0.00%
RRR 0.04 0.00%
DKE 0.15 0.00%
NNN 0.09 50.00%
DMTR 0.03 0.00%
BOIL 0.08 0.00%
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
SSIF 18.50 208.33%
FAR 6.50 176.60%
FAR 6.50 176.60%
FAR 6.50 176.60%
FAR 6.50 176.60%
CGW 55.03 107.66%
VENC 139.60 65.21%
0UTC 0.41 51.85%
NNN 0.09 50.00%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
0HFR
Daily Charts
0HFR
Intraday Charts
Whats New @
Bazaartrend
0HFR
Free Analysis
 
0HFR Important Levels Intraday
RESISTANCE11.23
RESISTANCE10.63
RESISTANCE10.26
RESISTANCE9.89
SUPPORT8.83
SUPPORT8.46
SUPPORT8.09
SUPPORT7.49
 
0HFR Forecast November 2024
4th UP Forecast13.72
3rd UP Forecast12.32
2nd UP Forecast11.46
1st UP Forecast10.59
1st DOWN Forecast8.13
2nd DOWN Forecast7.26
3rd DOWN Forecast6.4
4th DOWN Forecast5
 
0HFR Weekly Forecast
4th UP Forecast10.61
3rd UP Forecast10.21
2nd UP Forecast9.96
1st UP Forecast9.71
1st DOWN Forecast9.01
2nd DOWN Forecast8.76
3rd DOWN Forecast8.51
4th DOWN Forecast8.11
 
0HFR Forecast2024
4th UP Forecast23.14
3rd UP Forecast18.72
2nd UP Forecast15.99
1st UP Forecast13.26
1st DOWN Forecast5.46
2nd DOWN Forecast2.73
3rd DOWN Forecast0
4th DOWN Forecast-4.42
 
Anavex Life Sciences Corp. ( LSE UK Symbol : 0HFR )
Sector : N/A And Other Stocks in Same Sector
 
0HFR Other Details
Segment EQ
Market Capital 1011858496.00
Sector
Industry
Offical website >
 
0HFR Address
0HFR
 
0HFR Latest News
 
Your Comments and Response on Anavex Life Sciences Corp.
 
0HFR Business Profile
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials to treat Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company is based in New York, New York. Address: 51 West 52nd Street, New York, NY, United States, 10019
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service